Surgical Robot Wars (Motley Fool)
The stakes are getting higher. During the most recent MAKO Surgical (NASDAQ: MAKO) conference call, CEO Maurice Ferré noted that they have “gained increasing attention from competitors.” So the heat is officially on ... and this at a time when MAKO's sales have stumbled.
Who will come out on top of the struggle for robotic supremacy? That is the $64 question facing investors, and we have a lot more than $64 resting on the answer.
Traditional Surgical Providers
Most of MAKO’s competitors provide only implants and tools for traditional orthopedic surgery. They a...
